53PImmune-related adverse events correlate with clinical outcomes in non-small cell lung cancer (NSCLC) patients treated with nivolumab in the Italian expanded access programme
Baldini, E, Lunghi, A, Cortesi, E, Turci, D, Garassino, M C, Stati, V, Ardizzoni, A, Ricciuti, B, Frassoldati, A, Romano, G, Illiano, A, Verderame, F, Fasola, G, Marchetti, P, Pinto, C, Carteni, G, ScVolume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy486.005
Date:
December, 2018
File:
PDF, 94 KB
2018